Cargando…
IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer
Subnetwork analysis can explore complex patterns of entire molecular pathways for the purpose of drug target identification. In this article, the gene expression profiles of a cohort of patients with breast cancer are integrated with protein‐protein interaction (PPI) networks using, simultaneously,...
Autores principales: | Mounika Inavolu, S, Renbarger, J, Radovich, M, Vasudevaraja, V, Kinnebrew, GH, Zhang, S, Cheng, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351413/ https://www.ncbi.nlm.nih.gov/pubmed/28266149 http://dx.doi.org/10.1002/psp4.12167 |
Ejemplares similares
-
Identifying Drug Sensitivity Subnetworks with NETPHIX
por: Kim, Yoo-Ah, et al.
Publicado: (2020) -
De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet
por: Winkler, Sebastian, et al.
Publicado: (2022) -
Optimally discriminative subnetwork markers predict response to chemotherapy
por: Dao, Phuong, et al.
Publicado: (2011) -
Identifying differentially regulated subnetworks from phosphoproteomic data
por: Klammer, Martin, et al.
Publicado: (2010) -
Identifying stage-specific protein subnetworks for colorectal cancer
por: Erten, Sinan, et al.
Publicado: (2012)